Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
15 August 2022 |
Main ID: |
NCT03274401 |
Date of registration:
|
24/08/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Screening for Atrial Fibrillation in Pulmonary Embolism Study -SAFE-PE Study
SAFE-PE |
Scientific title:
|
Screening for Atrial Fibrillation in Pulmonary Embolism Study - SAFE-PE Study |
Date of first enrolment:
|
September 13, 2017 |
Target sample size:
|
90 |
Recruitment status: |
Terminated |
URL:
|
https://clinicaltrials.gov/show/NCT03274401 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Screening. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Sweden
| | | | | | | |
Contacts
|
Name:
|
Emma Svennberg, MD PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Karolinska Institutet - Danderyd Hospital |
|
Name:
|
Håkan Wallén, MD PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Karolinska Institutet - Danderyd Hospital |
| |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|